Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Finding the needle in the proteomic haystack

18.06.2010
Researchers at the RIKEN have demonstrated that a technique for tagging and profiling proteins can be used to accurately classify anti-cancer drugs based on the molecules they target. The technique promises to accelerate the process of proteomic profiling and contribute to more effective drug discovery.

Researchers at the RIKEN Advanced Science Institute have demonstrated that a technique for tagging and profiling proteins can be used to accurately classify anti-cancer drugs based on the molecules they target. The technique, developed in collaboration with a researcher at the University of Tsukuba, promises to accelerate the process of proteomic profiling and contribute to more effective drug discovery.

While essential for effective treatment, our understanding of the complex relationship between drugs and their molecular targets is far from complete. Drug efficacy is thus low, and drugs are often accompanied by dangerous side effects. Targeted cancer therapies, which act by interfering with specific molecules contributing to tumor growth, can bring therapeutic benefits to certain patients, yet are not free of these problems. Solving them depends on connecting drugs to their molecular targets, a task complicated by the huge variety of proteins and complexity of drug-target networks.

In recent years, the field of proteomics has produced powerful techniques that simplify this task by accurately identifying proteins and their interactions. The research team used one of these techniques, two-dimensional difference gel electrophoresis (2D-DIGE), to analyze and compare changes of protein expression levels in HeLa cancer cells treated with 19 well-known anti-cancer agents. The method successfully classified compounds of different structures but sharing molecular target(s), while revealing that compounds previously reported to inhibit the same process in fact were clustered into different groups, highlighting differences in underlying interaction mechanisms.

Described in the journal Chemistry and Biology, the findings broaden the scope of proteomic profiling by enabling researchers to characterize specific compounds in terms of how they interact with biomolecules. While refining the drug discovery process, this advance also contributes to minimizing side-effects, potentially supporting the future development of safer and more effective anticancer drugs.

For more information, please contact:

Dr. Hiroyuki Osada
Dr. Makoto Muroi
Chemical Library Validation Team
RIKEN Advanced Science Institute (ASI)
Tel: +81-(0)48-467-4839 / Fax: +81-(0)48-462-4669
Ms. Tomoko Ikawa (PI officer)
Global Relations Office
RIKEN
Tel: +81-(0)48-462-1225 / Fax: +81-(0)48-462-4715
Email: koho@riken.jp

gro-pr | Research asia research news
Further information:
http://www.riken.jp
http://www.researchsea.com

More articles from Life Sciences:

nachricht 'Y' a protein unicorn might matter in glaucoma
23.10.2017 | Georgia Institute of Technology

nachricht Microfluidics probe 'cholesterol' of the oil industry
23.10.2017 | Rice University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>